XML 38 R26.htm IDEA: XBRL DOCUMENT v3.25.0.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
3 Months Ended
Jan. 03, 2025
Accounting Policies [Abstract]  
Schedule of Cash and Cash Equivalents Cash and cash equivalents and restricted cash as reported within the Condensed Consolidated Statements of Cash Flows consisted of the following:
Three Months EndedThree Months Ended
January 3, 2025December 29, 2023
(In millions)Beginning of PeriodEnd of PeriodBeginning of PeriodEnd of Period
Cash and cash equivalents$168.7 $176.0 $152.6 $141.3 
Restricted cash1.7 125.8 1.4 1.4 
Total as presented in the Condensed Consolidated Statements of Cash Flows$170.4 $301.8 $154.0 $142.7 
Schedule of Restrictions on Cash and Cash Equivalents Cash and cash equivalents and restricted cash as reported within the Condensed Consolidated Statements of Cash Flows consisted of the following:
Three Months EndedThree Months Ended
January 3, 2025December 29, 2023
(In millions)Beginning of PeriodEnd of PeriodBeginning of PeriodEnd of Period
Cash and cash equivalents$168.7 $176.0 $152.6 $141.3 
Restricted cash1.7 125.8 1.4 1.4 
Total as presented in the Condensed Consolidated Statements of Cash Flows$170.4 $301.8 $154.0 $142.7 
Schedule of Customers with a Significant Portion of Revenue During the periods presented, one of the Company's customers accounted for a significant portion of revenues, as set forth below:
Three Months Ended
January 3, 2025December 29, 2023
Canon Medical Systems Corporation16.6 %14.7 %
Schedule of Product Warranty Liability The following table reflects the changes in the Company’s accrued product warranty:
Three Months Ended
(In millions)January 3, 2025December 29, 2023
Accrued product warranty, at beginning of period$10.8 $7.7 
New accruals charged to cost of revenues3.6 3.7 
Product warranty expenditures(3.7)(3.4)
Accrued product warranty, at end of period$10.7 $8.0